Search

Search Constraints

You searched for: Author/Creator Tu, M.

Search Results

1. A PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTORMODIFIED T CELLS DIRECTED AGAINST CD19 IN PATIENTS WITH RELAPSED OR REFRACTORYCD19(+) B CELL LYMPHOMAS: INTERIM ANALYSIS. (June 2017)

7. FIRST‐LINE L‐ASPARAGINASE‐BASED CHEMOTHERAPY PLUS RADIOTHERAPY IS ACTIVE IN STAGE I/II EXTRANODAL NK/T‐CELL LYMPHOMA: RESULTS FROM PEKING UNIVERSITY CANCER HOSPITAL. (June 2017)

9. P1090: CAMRELIZUMAB (CAM) COMBINED WITH GEMOX CHEMOTHERAPY RESULTS IN HIGH COMPLETE METABOLIC RESPONSE RATES IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA (CHL): A PHASE II TRIAL. (23rd June 2022)